ArticleOral and maxillofacial surgery2025
Ossification-deficient atypical ossifying fibromyxoid tumor of submandibular gland with PHF1::EP400 fusion: diagnostic challenges.
Article in Oral and maxillofacial surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundOssifying fibromyxoid tumor (OFMT) is a soft tissue neoplasm of uncertain differentiation, characterized by peripheral ossification within a fibromyxoid stroma and typically occurring in the extremities and trunk. However, OFMT arising from the submandibular gland is extremely rare. CASE PRESENTATION: A 40-year-old male presented with a progressively enlarging painless mass in the left submandibular region over two years. Radiological examination revealed a well-demarcated, round lesion measuring 1.3 cm in maximal diameter. Histopathology demonstrated nodular/lobular growth of uniform round-to-oval tumor cells with abundant eosinophilic cytoplasm, focal epithelioid features, and minimal atypia. Prominent myxoid stroma containing vascular networks was also observed in tumor. While peripheral infiltration was noted in small nests, resection margins were clear and perineural invasion absent. Immunohistochemistry showed diffuse S-100/vimentin positivity, focal weak desmin reactivity, and cytokeratin/CD34/SMA negativity. Next-generation sequencing (NGS) identified a pathogenic PHF1::EP400 fusion, confirming OFMT diagnosis despite absent calcification. The presence of infiltrative tumor cell growth warrants a diagnosis of atypical OFMT in this case. No recurrence occurred at 18-month follow-up.
conclusionIn this report, we present a rare case of OFMT arising in the submandibular region without histological evidence of ossification. This case give prominence to molecular detection in diagnosing morphologically ambiguous tumors and expands the clinicopathological spectrum of OFMT regarding anatomical distribution and histological variants.
Indexed as
Identifiers
41068353What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.